Literature DB >> 7833288

The C-terminus of the homeodomain is required for functional specificity of the Drosophila rough gene.

U Heberlein1, A Penton, S Falsafi, D Hackett, G M Rubin.   

Abstract

In contrast to most Drosophila homeobox genes, which are required during embryogenesis, the rough gene is involved in photoreceptor cell specification in the compound eye. Taking advantage of the viability of null rough alleles and the small size of the rough gene, we have combined in vivo and in vitro mutagenesis to define important functional domains in the rough protein. All missense mutations found to disrupt rough function mapped to highly conserved amino acids in the homeodomain (HD), suggesting that the nature of few, if any, single amino acids outside the HD is critical for rough activity. The analysis of chimeric proteins, in which the whole HD or parts of it were swapped between the rough and Antennapedia (Antp) proteins, revealed that the C-terminus of the rough HD is important for rough activity in vivo. This C-terminal region was also found to be required for the recognition of rough binding sites in vitro. Our data suggest that amino acids located in the C-terminus of the homeodomain may play important roles in selective binding site recognition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833288     DOI: 10.1016/0925-4773(94)90004-3

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  3 in total

1.  Single amino acid mutations in Drosophila fascin disrupt actin bundling function in vivo.

Authors:  K Cant; L Cooley
Journal:  Genetics       Date:  1996-05       Impact factor: 4.562

2.  In vivo Structure/Function analysis of the Drosophila fat facets deubiquitinating enzyme gene.

Authors:  X Chen; J A Fischer
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

3.  Two-step selection of a single R8 photoreceptor: a bistable loop between senseless and rough locks in R8 fate.

Authors:  Kathryn L Pepple; Mardelle Atkins; Koen Venken; Kari Wellnitz; Mark Harding; Benjamin Frankfort; Graeme Mardon
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.